A novel complex mutant β-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum β-lactamase- producing klebsiellae

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1499-1505

  Fiett, Janusz ^a   Pałucha, Andrzej ^b   Miaczyńska, Beata ^c   Stankiewicz, Maria ^c   Przondo Mordarska, Hanna ^c   Hryniewicz, Waleria ^a   Gniadkowski, Marek ^a  

^a Sera & Vaccines Central Research Laboratory Warszawa   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINO ACID; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CLAVULANIC ACID; DNA; GENTAMICIN; IMIPENEM; PIPERACILLIN; TAZOBACTAM;

AMINO ACID SUBSTITUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; ENZYME ACTIVITY; EPIDEMIC; GENE; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

BETA-LACTAMASES; DISEASE OUTBREAKS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MUTATION; POLAND;

EID: 0343183284     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1499-1505.2000     Document Type: Article

References (45)

1. Ambler, R. P., A. F. W. Coulson, J.-M. Frère, J. M. Ghuysen, B. Joris, M. Foreman, R. C. Levesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A β-lactamases. Biochem J. 276:269-270.
2. Amyes, S. G. B., and R. S. Miles. 1998. Extended-spectrum β-lactamases: the role of inhibitors in therapy. J. Antimicrob. Chemother. 42:415-417.
3. Bauernfeind, A., J. M. Casellas, M. Goldberg, M. Holley, R. Jungwirth, P. Mangold, T. Röhnisch, S. Schweighart, and R. Wilhelm. 1992. A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection 20:158-163.
4. PER.2, which encodes an extended-spectrum class A β-lactamase. Antimicrob. Agents Chemother. 40:616-620.
5. Billot-Klein, D., L. Gutmann, and E. Collatz. 1990. Nucleotide sequence of the SHV-5 β-lactamase gene of a Klebsiella pneumoniae plasmid. Antimicrob. Agents Chemother. 34:2439-2441.
6. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523.
7. Bradford, P. A., C. E. Cherubin, V. Idemyor, B. A. Rasmussen, and K. Bush. 1994. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate. Antimicrob. Agents. Chemother. 38:761-766.
8. Bradford, P. A., C. Urban, A. Jaiswal, N. Mariano, B. A. Rasmussen, S. J. Projan, J. J. Rahal, and K. Bush. 1995. SHV-7, a novel cefotaxime-hydrolyzing β-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients. Antimicrob. Agents Chemother. 39:899-905.
9. Bret, L., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1996. Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 β-lactamase produced by Proteus mirabilis strains. J. Antimicrob. Chemother. 38:183-191.
10. Bush, K., C. Macalintal, B. A. Rasmussen, V. J. Lee, and Y. Yang. 1993. Kinetic interactions of tazobactam with β-lactamases from all major structural classes. Antimicrob. Agents Chemother. 37:851-858.
11. Caniça, M. M., M. Barthélémy, L. Gilly, R. Labia, R. Krishnamoorthy, and G. Paul. 1997. Properties of IRT-14 (TEM-45), a newly characterized mutant of TEM-type β-lactamases. Antimicrob. Agents Chemother. 41:374-378.
12. Chen, S. T., and R. Clowes. 1987. Variations between the nucleotide sequences of Tn1, Tn2, and Tn3 and expression of β-lactamase in Pseudomonas aeruginosa and Escherichia coli. J. Bacteriol. 169:913-916.
13. Churchward, G., D. Belin, and Y. Nagamine. 1984. A pSC101-derived plasmid which shows no sequence homology to other commonly used cloning vectors. Gene 31:165-171.
14. Gniadkowski, M., A. Pałucha, P. Grzesiowski, and W. Hryniewicz. 1998. Outbreak of ceftazidime-resistant Klebsiella pneumoniae in a pediatric hospital in Warsaw, Poland: clonal spread of the TEM-47 extended-spectrum β-lactamase (ESBL)-producing strain and transfer of a plasmid carrying the SHV-5-like ESBL-encoding gene. Antimicrob. Agents Chemother. 42:3079-3085
15. Gniadkowski, M., I. Schneider, R. Jungwirth, W. Hryniewicz, and A. Bauemfeind. 1998. Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 42:514-520.
16. Gouby, A., C. Neuwirth, G. Bourg, N. Bouziges, M. J. Carles-Nurit, E. Despaux, and M. Ramuz. 1994. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J. Clin. Microbiol. 32:301-305.
17. Goussard, S., and P. Courvalin. 1991. Sequences of the genes bla-T1b b and bla-T2. Gene 102:71-73.
18. Henquell, C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1995 Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM β-lactamases from clinical isolates of Escherichia coli. Anti-microb. Agents Chemother. 39:427-430.
19. Jarlier, V., M. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
20. Kitzis, M. D., D. Billot-Klein, F. W. Goldstein, R. Williamson, G. Tran Van Nhieu, J. Carlet, J. F. Acar, and L. Gutmann. 1988 Dissemination of the novel plasmid-mediated β-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by β-lactamase inhibitors. Antimicrob. Agents Chemother. 32:9-14.
21. Knox, J. R. 1995. Extended-spectrum and inhibitor-resistant TEM-type β-lactamases: mutations, specificity, and three-dimensional structure. Anti-microb. Agents Chemother. 39:2593-2601.
22. Legakis, N. J., L. S. Tzouvelekis, G. Hatzoudis, E. Tzelepi, A. Gourkou, T. L. Pitt, and A. C. Vatopoulos. 1995. Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type beta-lactamase. J. Hosp. Infect. 31:177-187.
23. Lemozy, J., D. Sirot, C. Chanal, C. Huc, R. Labia, H. Dabernat, and J. Sirot. 1995. First characterization of inhibitor-resistant TEM (IRT) β-lactamases in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 39:2580-2582.
24. Livermore, D. M. 1995. β-Lactamases in laboratory and clinical resistance. Clin. Microbiol. Rev. 8:557-584.
25. Mabilat, C., S. Goussard, W. Sougakoff, R. C. Spencer, and P. Courvalin. 1990. Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum β-lactamase TEM-9 (RHH-I) of Klebsiella pneumoniae. Plasmid 23:1-8.
26. Matthew, M., A. M. Harris, M. J. Marshall, and G. W. Ross. 1975 The use of analytical isoelectric focussing for detection and identification of β-lactamases. J. Gen. Microbiol. 88:169-178.
27. Medeiros, A. A. 1997. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin. Infect. Dis. 24(Suppl. 1): S19-545.
28. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. Performance standards for antimicrobial susceptibility testing; ninth informational supplement, January 1999. National Committee for Clinical Laboratory Standards. Wayne, Pa.
29. Nicolas-Chanoine, M. H. 1997. Inhibitor-resistant β-lactamases. J. Antimicrob. Cbemother. 40:1-3.
30. Palucha, A., B. Mikiewicz, and M. Gniadkowski. 1999. Diversification of the Escherichia coli expressing an SHV-type extended-spectrum β-lactamase (ESBL) during a hospital outbreak: emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 43:393-396.
31. Palucha, A., B. Mikiewicz, W. Hryniewicz, and M. Gniadkowski. 1999. Concurrent outbreaks of extended-spectrum β-lactamase-producing organisms of the family Enterobacteriaceae in a Warsaw hospital. J. Antimicrob. Chemother. 44:489-499.
32. Poyart, C., P. Mugnier, G. Quesne, P. Berche, and P. Trieu-Cuot. 1998. A novel extended-spectrum TEM-type β-lactamase (TEM-52) associated with decreased susceptibility to moxalactam in Klebsiella pneumonia?. Antimicrob. Agents Chemother. 42:108-113.
33. Prinarakis, E. E., V. Miriagou, E. Tzelepi, M. Gazouli, and L. S. Tzouvelekis. 1997. Emergence of an inhibitor-resistant β-lactamase (SHV-10) derived from an SHV-5 variant. Antimicrob. Agents Chemother. 41:838-840.
34. Rasheed, J. K., C. Jay, B. Metchock, F. Berkowitz, L. Weigel, J. Crellin, S. Steward, B. Hill, A. A. Medeiros, and F. C. Tenover. 1997. Evolution of extended-spectrum β-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob. Agents Chemother. 41:647-653.
35. Renders, N., A. van Belkum, A. Barth, W. Goessens, J. Mouton, and H. Verbrugh. 1996. Typing of Pseudomonas, aeruginosa strains from patients with cystic fibrosis: phenotyping versus genotyping. Clin. Microbiol. Infect. 1: 261-265.
36. Rice, L. B., E. C. Eckstein, J. DeVente, and D. M. Shlaes. 1996. Ceftazidimeresistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin. Infect. Dis. 23: 118-124.
37. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
38. Shannon, K. P., A. King, I. Philips, M. H. Nicolas, and A. Philippon. 1990. Importation of organisms producing broad-spectrum SHV-group β-lactamases into the United Kingdom. J. Antimicrob. Chemother. 25:343-351.
39. Sirot, D., R. Labia, P. Pouedras, C. Chanal-Claris, C. Cercereau, and J. Sirot. 1998. Inhibitor-resistant OXY-2-derived β-lactamase produced by Klebsiella oxytoca. Antimicrob. Agents Chemother. 42:2184-2187.
40. Sirot, D., C. Recule, E. B. Chaibi, L. Bret, J. Croize, C. Chanal-Claris, R. Labia, and J. Sirot. 1997. A complex mutant of TEM-1 β-lactamase with mutations encountered in both IRT-4 and extended-spectrum TEM-15, produced by an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 41:1322-1325.
41. Struelens, M. J., F. Rost, A. Deplano, A. Maas, V. Schwam, E. Serruys, and M. Cremer. 1993. Pseudomonas aeruginosa and Enterobacteriaceae bacteremia after biliary endoscopy: an outbreak investigation using DNA macrorestriction analysis. Am. J. Med. 95:489-498.
42. Sutcliffe, J. 1978. Nucleotide sequence of the ampicilliri-resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75:3737-3741.
43. Tenover, F. C., R. D. Arbeit, V. R. Goering, P. A. Mickelsen, B. E. Murray, D. H. Pershing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
44. Thomson, C. J., and S. G. B. Amyes. 1992. TRC-1: emergence of clavulanic acid-resistant TEM β-lactamase in a clinical strain. FEMS Microbiol. Lett. 91:113-118.
45. Vedel, G., A. Belaaouaj, L. Gilly, R Labia, A. Philippon, P. Nevot, and G. Paul. 1992. Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitors. J. Anti-microb. Chemother. 30:449-462.